Role of donor and recipient antigen-presenting cells in priming and maintaining t cells with indirect allospecificity

Transplantation

Volumn 66, Issue 9, 1998, Pages 1238-1243

  Frasca, Loredana ^a   Amendola, Alessandra ^a   Hornick, Phil ^a   Brookes, Paul ^a   Aichinger, Gerald ^a   Marelli Berg, Federica ^a   Lechler, Robert Ian ^a   Lombardi, Giovanna ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; SYNTHETIC PEPTIDE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032533816     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199811150-00020     Document Type: Article

References (33)

1. Sharrock CRM, Man S, Wanachiwanawin W, Batchelor JR. Analysis of the alloreactive T cell repertoire in man. Transplantation 1987; 43: 699.
2. Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach F. Molecular basis of allorecognition. Immunol Today 1990; 11: 83.
3. Matzinger P, Bevan MJ. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol 1977; 29: 1.
4. Bevan MJ. High determinant density may explain the phenomenon of alloreactivity. Immunol Today 1984; 5: 128.
5. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
6. Bal V, McIndoe A, Denton G, Hudson D, Lombardi G, Lamb J, Lechler RI. Antigen presentation by keratinocyte induces tolerance in human T cells. Eur J Immunol 1990; 20: 1893.
7. Wilson LJ, Proud G, Forsythe JLR, Taylor RMR, Kirby JA. Renal allograft rejection. Transplantation 1995; 59: 91.
8. Marelli-Berg FM, Hargreaves REG, Carmichael P, Dorling A, Lombardi G, Lechler RI. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med 1996; 183: 1603.
9. Marelli-Berg FM, Weetman A, Frasca L, et al. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells. J Immunol 1997; 159: 5853.
10. Lombardi G, Arnold K, Uren J, et al. Antigen presentation by interferon-g-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells. Eur J Immunol 1997; 27: 62.
11. De Koster HS, Anderson DC, Termijtelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med 1989; 169: 1191.
12. Essaket S, Fabron J, De Preval C, Thomsen M. Corecognition of HLA-A1 and HLA-DPw3 by a human CD4+ alloreactive T lymphocyte clone. J Exp Med 1990; 172: 387.
13. Chen BP, Madrigal A, Parham P. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J Exp Med 1990; 172: 779.
14. Liu Z, Sun YK, Xi YP, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993. 177: 1643.
15. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
16. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
17. Dalchau R, Fangmann J, Fabre JW. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex mecules: evidence for an important role for indirect allorecognition in transplantation. Eur J Immunol 1992; 22: 669.
18. Fangmann J, Dalchau R, Sawyer GJ, Priestley CA, Fabre JW. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur J Immunol 1992; 22: 1525.
19. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allo-recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572.
20. Gallon L, Watschinger B, Murphy B, Akalin E, Sayegh MH, Carpenter CB. The indirect pathway of allorecognition: the occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995; 59: 612.
21. Benham Am, Sawyer GJ, Fabre JW. Indirect T cell recognition of donor antigens contributes to the rejection of vascularized kidney allograft. Transplantation 1995; 59: 1028.
22. Auchincloss H, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
23. Sherwood RA, Brent L, Rayfield LS. Presentation of alloantigens by host cells. Eur J Immunol 1986; 16: 569.
24. Van Besouw NM, Vaessen LMB, Daane CR, et al. Peripheral monitoring of direct and indirect alloantigen presentation pathways in clinical heart transplant recipients. Transplantation 1996; 61: 165.
25. Liu Z, Colovai AI, Tugulea S, et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996; 98: 1150.
26. Vella JP, Spadafor-Ferreira M, Murphy B, et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795.
27. Neitzel J. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 1986; 73: 320.
28. Matsumura M, Saito Y, Jackson MR, Song ES, Peterson PA. In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J Biol Chem 1992; 267: 23589.
29. Hornick P, Brookes P, Mason P, Lechler RI. Optimising a limiting dilution culture system for quantifying the frequency of IL-2 producing alloreactive helper T lymphocytes. Transplantation 1997; 64: 472.
30. Finney D. Statistical method in biological assay. London: Charles Griffin, 1978.
31. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27.
32. Singer GG, Yokoyama H, Bloom RD, Jenkinar AM, Nabavi N, Keley VR. Stimulated renal tubular epithelial cells induce anergy in CD4+ T cells. Kidney Int 1993; 44: 1030.
33. Frasca L, Marelli-Berg FM, Imami N, et al. Interferon-γ-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int 1998; 53: 679.